We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.98B
AUM Growth
+$70.5M
Cap. Flow
-$33M
Cap. Flow %
-1.66%
Top 10 Hldgs %
15.03%
Holding
324
New
29
Increased
50
Reduced
187
Closed
28

Sector Composition

Rank Sector Weight
1 Healthcare 19.12%
2 Industrials 18.8%
3 Technology 17.6%
4 Consumer Discretionary 14.29%
5 Financials 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLP icon
251
Simulations Plus
SLP
$371M
$778K 0.04%
80,646
+14,035
+21% +$127K
IWC icon
252
iShares Micro-Cap ETF
IWC
$1.52B
$758K 0.04%
8,829
+5,362
+155% +$431K
ZBH icon
253
Zimmer Biomet
ZBH
$18.4B
$727K 0.04%
7,258
-1
-0% -$107
BMRN icon
254
BioMarin Pharmaceuticals
BMRN
$12.4B
$711K 0.04%
+8,588
New +$739K
SRCL
255
DELISTED
Stericycle Inc
SRCL
$684K 0.03%
+8,880
New +$671K
LHX icon
256
L3Harris
LHX
$53.4B
$652K 0.03%
6,366
CVX icon
257
Chevron
CVX
$366B
$633K 0.03%
5,375
BBRG
258
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
$611K 0.03%
160,668
-21,194
-12% -$89.8K
PII icon
259
Polaris
PII
$4.07B
$571K 0.03%
+6,935
New +$566K
ICUI icon
260
ICU Medical
ICUI
$4.61B
$533K 0.03%
3,615
+613
+20% +$88.7K
WM icon
261
Waste Management
WM
$91B
$532K 0.03%
7,500
MRK icon
262
Merck
MRK
$318B
$530K 0.03%
9,436
BRK.A icon
263
Berkshire Hathaway Class A
BRK.A
$1.12T
$488K 0.02%
2
NOV icon
264
NOV
NOV
$7B
$476K 0.02%
12,726
MNK
265
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$469K 0.02%
+9,406
New +$554K
T icon
266
AT&T
T
$163B
$455K 0.02%
14,163
INTC icon
267
Intel
INTC
$513B
$454K 0.02%
12,525
-250
-2% -$8.95K
WBA
268
DELISTED
Walgreens Boots Alliance
WBA
$430K 0.02%
5,200
VNDA icon
269
Vanda Pharmaceuticals
VNDA
$302M
$429K 0.02%
26,885
+4,542
+20% +$73K
NRCIB
270
DELISTED
National Research Corp Class B
NRCIB
$405K 0.02%
9,714
+1,634
+20% +$62.8K
MMM icon
271
3M
MMM
$94.3B
$402K 0.02%
2,692
CSGP icon
272
CoStar Group
CSGP
$12.3B
$400K 0.02%
+21,230
New +$417K
TEVA icon
273
Teva Pharmaceuticals
TEVA
$41.2B
$393K 0.02%
10,850
MCO icon
274
Moody's
MCO
$82.7B
$370K 0.02%
3,929
BMY icon
275
Bristol-Myers Squibb
BMY
$132B
$367K 0.02%
6,288

Similar funds

Rice Hall James & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Rice Hall James & Associates held 324 positions worth $1.98B, up 3.7% from $1.91B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Rice Hall James & Associates's Q4 2016 filing shows 29 new, 50 increased, 187 reduced and 28 closed positions. Its largest new stake was Interface: 948,022 shares worth $17.6M. The largest sale was Fleetmatics Group PLC, an estimated $21M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q4 2016 buy was Interface: 948,022 shares worth $17.6M.
  • Rice Hall James & Associates added most to Fabrinet in Q4 2016, an estimated $19.6M increase.
  • Rice Hall James & Associates's biggest Q4 2016 reduction was Tetra Tech, cutting an estimated $9.71M.
  • Rice Hall James & Associates fully exited Fleetmatics Group PLC in Q4 2016, selling an estimated $21M.
  • Rice Hall James & Associates's ten largest holdings make up 15% of its $1.98B portfolio in Q4 2016.
  • Rice Hall James & Associates opened 29 new positions and closed 28 in Q4 2016.
  • Rice Hall James & Associates's portfolio value rose 3.7% quarter-over-quarter to $1.98B.

Based on Rice Hall James & Associates's 13F filing for Q4 2016, filed 2 Feb 2017.